PTK2 and cancer: Under DNA damage conditions, protein tyrosine kinase 2 (PTK2) phosphorylates ATG3 at the Tyr203 site and promotes the degradation of ATG3 through the ubiquitin-dependent proteasome pathway, resulting in positively regulating the activity of cancer cells [71].